Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Post by SouthernTierTomon Apr 15, 2021 5:39pm
178 Views
Post# 33007865

Stay the course mates, the FDA bladder cancer trial...

Stay the course mates, the FDA bladder cancer trial...is what this firm is all about...

The current phase II FDA study complete with fast-track should and would normally drive valuation many multiples of where we are.  Almost makes you wonder if the FDA bladder cancer initiative is "too good", I am beginning to think this is another one of those UHN high grade science low grade marketing plays.  

The PUMP and CHURN of the 55 cent stock prior to the 30 cent financing and the 35 cent warrants was indeed disgusting....remember too that 12.7 MILLION options were "doled out" to management types at 25 cents CAD just weeks after Joe Retail was pumped hard and put away broke by this disgusting and rather "organized" bullboard...

My barn door is always open if someone wants to inbox me, my experience following this bullboard and the "fine fellows" that run it is rather extensive ; - )

FIRST CLASS trial sites, well done to TLTFF management!! Really a shame that this full-time bullboard has to taint the wonderful technology at work!  Stick with it fellas, I'm on your side!!

Contacts
Contact: Shawn Shirazi, Ph.D 416-699-5273 ext 229 sshirazi@theralase.com  
Contact: Arkady Mandel, MD, Ph.D. 416-699-5273 ext 242 amandel@theralase.com  

Locations
United States, Pennsylvania
Site 02008 - MidLantic Urology Recruiting
Bala-Cynwyd, Pennsylvania, United States, 19087
Contact: Cheryl Zinar    610-667-0458    czinar@ucsepa.com   
Principal Investigator: Dr. Laurence Belkoff, MD         
United States, South Carolina
Site 02006 - Carolina Urologic Research Center Recruiting
Myrtle Beach, South Carolina, United States, 29572
Contact: Stacy Rust    843-449-1010    srust@curcmb.com   
Principal Investigator: Dr. Neal Shore, MD         
United States, Tennessee
Site 02007 - Urology Associates, P. C Recruiting
Nashville, Tennessee, United States, 37209
Contact: Aryssa Hudson    615-250-9282    aehudson@ua-pc.com   
Principal Investigator: Dr. Gautam Jayram         
United States, Texas
Site 02010 - Urology San Antonio P. A Recruiting
San Antonio, Texas, United States, 78229
Contact: Kethsaly Salinas    210-617-4116    kethsaly.Salinas@urologysa.com   
Principal Investigator: Dr. Daniel Saltzstein, MD         
United States, Virginia
Site 02009 - Virginia Urology Recruiting
Richmond, Virginia, United States, 23235
Contact: Christine Rose    804-288-2785    clrose@uro.com   
Principal Investigator: Dr. Eugene Kramolowsky, MD         
United States, Wisconsin
Site 02011 - University of Wisconsin Health Recruiting
Madison, Wisconsin, United States, 53705
Contact: Sarah Sund    608-265-0027    Sund@ortho.wisc.edu   
Principal Investigator: Dr. Kyle Richards, MD         
Canada, British Columbia
Site 01005 - The Vancouver Prostate Centre - Diamond Health Care Centre Recruiting
Vancouver, British Columbia, Canada, V5Z 1M9
Contact: Genevive Moreau    604-875-5003    gbaloloy@prostatecentre.com   
Principal Investigator: Peter Black, MD         
Canada, Nova Scotia
Site 01004 - Nova Scotia Health Authority - Centre for Urology Research Recruiting
Halifax, Nova Scotia, Canada
Contact: Natasha Duggan, B.A.         
Principal Investigator: Ricardo Rendon, M.D.         
Sub-Investigator: Ross Mason, M.D.         
Canada, Ontario
Site 01002- London Health Sciences Centre Recruiting
London, Ontario, Canada
Contact: Wendy Shoff         
Principal Investigator: Joseph Chin, MD         
Site 01001 - University Health Network Recruiting
Toronto, Ontario, Canada, M5G 2C4
Contact: Michael Nesbitt         
Principal Investigator: Girish Kulkarni, MD         
Canada, Quebec
Site 01003 - McGill University Health Centre Recruiting
Montral, Quebec, Canada
Contact: Raphael Freitas         
Principal Investigator: Wassim Kassouf, MD 

<< Previous
Bullboard Posts
Next >>